Welcome to LookChem.com Sign In|Join Free

CAS

  • or

40172-95-0

Post Buying Request

40172-95-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

40172-95-0 Usage

Chemical Properties

white to light yellow solid

Uses

Different sources of media describe the Uses of 40172-95-0 differently. You can refer to the following data:
1. 2-Furanyl-1-piperazinylmethanone was utilized in the fragment-based design of symmetrical bis-benzimidazole as inhibitors of R67 dihydrofolate reductase.
2. 2-Furanyl-1-piperazinylmethanone (Terazosin EP Impurity L) was utilized in the fragment-based design of symmetrical bis-benzimidazole as inhibitors of R67 dihydrofolate reductase.
3. 1-(2-Furoyl)piperazine may be used to synthesize: 2-[4-(2-furoyl) piperazin-1-yl]-4-amino-6-benzyloxy-7-methoxyquinazoline hydrochloride monohydrate2-[4-(2-furoyl)piperazin-1-yl]-4-amino-7-benzyloxy-6-methoxyquinazoline hydrochloride monohydrate4-amino-2-[4-(2-furoyl)piperazin-1-yl]-quinazoline hydrochloride6,7-dimethoxy-2-[4-(2-furoyl)-piperazin-1-yl]quinazoline-4-one hydrate1-[2-(3,4-dimethoxyphenyl)ethyl]-4-(2-furoyl)-piperazine hydrogen oxalate1-(3,4-dichlorobenzyl)-4-(2-furoyl)-piperazine hydrogen oxalate4-(9-fluorenyl)-1-(2-furoyl)piperazine2-[4-(2-furoyl)piperazin-1-yl]-benzimidazole hydrochloride hydrate

Synthesis Reference(s)

Journal of Medicinal Chemistry, 20, p. 146, 1977 DOI: 10.1021/jm00211a031

Check Digit Verification of cas no

The CAS Registry Mumber 40172-95-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,0,1,7 and 2 respectively; the second part has 2 digits, 9 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 40172-95:
(7*4)+(6*0)+(5*1)+(4*7)+(3*2)+(2*9)+(1*5)=90
90 % 10 = 0
So 40172-95-0 is a valid CAS Registry Number.
InChI:InChI=1/C9H12N2O2/c12-9(8-2-1-7-13-8)11-5-3-10-4-6-11/h1-2,7,10H,3-6H2/p+1

40172-95-0 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (A16773)  1-(2-Furoyl)piperazine, 98%   

  • 40172-95-0

  • 25g

  • 825.0CNY

  • Detail
  • Alfa Aesar

  • (A16773)  1-(2-Furoyl)piperazine, 98%   

  • 40172-95-0

  • 100g

  • 2948.0CNY

  • Detail
  • Alfa Aesar

  • (A16773)  1-(2-Furoyl)piperazine, 98%   

  • 40172-95-0

  • 500g

  • 11823.0CNY

  • Detail
  • Sigma-Aldrich

  • (Y0000623)  TerazosinimpurityL  European Pharmacopoeia (EP) Reference Standard

  • 40172-95-0

  • Y0000623

  • 1,880.19CNY

  • Detail
  • Aldrich

  • (558966)  1-(2-Furoyl)piperazine  97%

  • 40172-95-0

  • 558966-25G

  • 712.53CNY

  • Detail

40172-95-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-(2-Furoyl)piperazine

1.2 Other means of identification

Product number -
Other names furan-2-yl(piperazin-1-yl)methanone

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:40172-95-0 SDS

40172-95-0Synthetic route

piperazine
110-85-0

piperazine

2-furanoic acid
88-14-2

2-furanoic acid

N-(furan-2-carbonyl)piperazine
40172-95-0

N-(furan-2-carbonyl)piperazine

Conditions
ConditionsYield
With 4-methyl-morpholine; 2-chloro-4,6-dimethoxy-1 ,3,5-triazine In dichloromethane at 20℃; for 0.166667h;92%
Stage #1: 2-furanoic acid With N-Bromosuccinimide; triphenylphosphine In dichloromethane at 0 - 5℃; for 0.25h;
Stage #2: piperazine With pyridine In dichloromethane at 20℃; for 0.583333h;
86%
piperazine
110-85-0

piperazine

Ethyl 2-furoate
614-99-3

Ethyl 2-furoate

A

N,N'-bis(furan-2-carbonyl)piperazine
31350-27-3

N,N'-bis(furan-2-carbonyl)piperazine

B

N-(furan-2-carbonyl)piperazine
40172-95-0

N-(furan-2-carbonyl)piperazine

Conditions
ConditionsYield
at 110℃; for 3h;A 6%
B 89%
piperazine
110-85-0

piperazine

2-furanoic acid
88-14-2

2-furanoic acid

A

N,N'-bis(furan-2-carbonyl)piperazine
31350-27-3

N,N'-bis(furan-2-carbonyl)piperazine

B

N-(furan-2-carbonyl)piperazine
40172-95-0

N-(furan-2-carbonyl)piperazine

Conditions
ConditionsYield
With 1,1,1,3,3,3-hexamethyl-disilazane at 110℃; for 8h; Yields of byproduct given;A n/a
B 83%
piperazine
110-85-0

piperazine

2-furanoic acid
88-14-2

2-furanoic acid

1,1,1,3,3,3-hexamethyl-disilazane
999-97-3

1,1,1,3,3,3-hexamethyl-disilazane

N-(furan-2-carbonyl)piperazine
40172-95-0

N-(furan-2-carbonyl)piperazine

Conditions
ConditionsYield
In dichloromethane83%
piperazine
110-85-0

piperazine

2-furoic acid methyl ester
611-13-2

2-furoic acid methyl ester

N-(furan-2-carbonyl)piperazine
40172-95-0

N-(furan-2-carbonyl)piperazine

Conditions
ConditionsYield
64%
2-furancarbonyl chloride
527-69-5

2-furancarbonyl chloride

1-t-Butoxycarbonylpiperazine
57260-71-6

1-t-Butoxycarbonylpiperazine

N-(furan-2-carbonyl)piperazine
40172-95-0

N-(furan-2-carbonyl)piperazine

Conditions
ConditionsYield
With hydrogenchloride; triethylamine 1.) THF, r.t., 2 h, 2.) THF, 20 deg C, 2 h; Yield given. Multistep reaction;
piperazine
110-85-0

piperazine

2-furancarbonyl chloride
527-69-5

2-furancarbonyl chloride

N-(furan-2-carbonyl)piperazine
40172-95-0

N-(furan-2-carbonyl)piperazine

Conditions
ConditionsYield
With sodium hydroxide; hydrogen bromide; potassium carbonate 1.) aq. monoglyme, 3 h; Yield given. Multistep reaction;
2-furancarbonyl chloride
527-69-5

2-furancarbonyl chloride

piperazine hexahydrate
142-63-2

piperazine hexahydrate

N-(furan-2-carbonyl)piperazine
40172-95-0

N-(furan-2-carbonyl)piperazine

Conditions
ConditionsYield
With sodium hydroxide In water108.2 g product (60%)
With sodium hydroxide In water108.2 g product (60%)
With sodium hydroxide In water108.2 g product (60%)
With sodium hydroxide In water108.2 g product (60%)
With sodium hydroxide108.2 g. product (60%)
piperazine
110-85-0

piperazine

2-furancarbonyl chloride
527-69-5

2-furancarbonyl chloride

1-cyano-4-(2-furoyl)piperazine

1-cyano-4-(2-furoyl)piperazine

N-(furan-2-carbonyl)piperazine
40172-95-0

N-(furan-2-carbonyl)piperazine

Conditions
ConditionsYield
With hydrogenchloride; sodium hydroxide In diethyl ether; ethanol; acetone
tert-butyl 4-(furan-2-carbonyl)piperazine-1-carboxylate

tert-butyl 4-(furan-2-carbonyl)piperazine-1-carboxylate

N-(furan-2-carbonyl)piperazine
40172-95-0

N-(furan-2-carbonyl)piperazine

Conditions
ConditionsYield
Acidic conditions;
With hydrogenchloride; water In dichloromethane at 20℃;
With hydrogenchloride In methanol; diethyl ether
2-furancarbonyl chloride
527-69-5

2-furancarbonyl chloride

N-(furan-2-carbonyl)piperazine
40172-95-0

N-(furan-2-carbonyl)piperazine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: triethylamine / dichloromethane / 20 °C
2: hydrogenchloride; water / dichloromethane / 20 °C
View Scheme
2-furanoic acid
88-14-2

2-furanoic acid

N-(furan-2-carbonyl)piperazine
40172-95-0

N-(furan-2-carbonyl)piperazine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine / dichloromethane / 18 h / 20 °C
2: trifluoroacetic acid / dichloromethane / 25 °C
View Scheme
Multi-step reaction with 2 steps
1: O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate / dichloromethane / 20 °C
2: trifluoroacetic acid / dichloromethane / 1 h / 20 °C
View Scheme
Isopropenyl acetate
108-22-5

Isopropenyl acetate

N-(furan-2-carbonyl)piperazine
40172-95-0

N-(furan-2-carbonyl)piperazine

1-(4-(furan-2-carbonyl)piperazin-1-yl)ethanone
768292-07-5

1-(4-(furan-2-carbonyl)piperazin-1-yl)ethanone

Conditions
ConditionsYield
In neat (no solvent) at 20℃; for 1h; Green chemistry;100%
2-Chloroethanesulfonyl chloride
1622-32-8

2-Chloroethanesulfonyl chloride

N-(furan-2-carbonyl)piperazine
40172-95-0

N-(furan-2-carbonyl)piperazine

4-(4-((p-methylbenzylamino)methyl)-3-methoxyphenoxy)butyryl AM resin

4-(4-((p-methylbenzylamino)methyl)-3-methoxyphenoxy)butyryl AM resin

2-[4-(furan-2-carbonyl)-piperazin-1-yl]-ethanesulfonic acid 4-methyl-benzylamide

2-[4-(furan-2-carbonyl)-piperazin-1-yl]-ethanesulfonic acid 4-methyl-benzylamide

Conditions
ConditionsYield
Stage #1: 2-Chloroethanesulfonyl chloride; 4-(4-((p-methylbenzylamino)methyl)-3-methoxyphenoxy)butyryl AM resin With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃; for 2h; solid phase reaction;
Stage #2: N-(furan-2-carbonyl)piperazine With lithium perchlorate In dichloromethane; isopropyl alcohol at 75℃; for 24h; Michael addition;
Stage #3: With trifluoroacetic acid In water for 1h;
99%
6-ethoxycarbonyl-7-chlorothieno<3,2-b>pyridin-5(4H)-one
83178-89-6

6-ethoxycarbonyl-7-chlorothieno<3,2-b>pyridin-5(4H)-one

N-(furan-2-carbonyl)piperazine
40172-95-0

N-(furan-2-carbonyl)piperazine

7-[4-(furan-2-carbonyl)piperazin-1-yl]-5-oxo-4,5-dihydro-thieno[3,2-b]pyridine-6-carboxylic acid ethyl ester

7-[4-(furan-2-carbonyl)piperazin-1-yl]-5-oxo-4,5-dihydro-thieno[3,2-b]pyridine-6-carboxylic acid ethyl ester

Conditions
ConditionsYield
With 1,4-diaza-bicyclo[2.2.2]octane In ISOPROPYLAMIDE at 120℃; for 2 - 4h;99%
6-bromo-2-chloroquinazolin-4-amine
111218-89-4

6-bromo-2-chloroquinazolin-4-amine

N-(furan-2-carbonyl)piperazine
40172-95-0

N-(furan-2-carbonyl)piperazine

[4-(4-Amino-6-bromo-quinazolin-2-yl)-piperazin-1-yl]-furan-2-yl-methanone; hydrochloride
111218-73-6

[4-(4-Amino-6-bromo-quinazolin-2-yl)-piperazin-1-yl]-furan-2-yl-methanone; hydrochloride

Conditions
ConditionsYield
In N,N-dimethyl-formamide at 95℃; for 14h;96.4%
carbon disulfide
75-15-0

carbon disulfide

N-(furan-2-carbonyl)piperazine
40172-95-0

N-(furan-2-carbonyl)piperazine

sodium 4-(furan-2-carbonyl)piperazine-1-carbodithioate

sodium 4-(furan-2-carbonyl)piperazine-1-carbodithioate

Conditions
ConditionsYield
With sodium hydroxide In methanol at 0℃; for 3h;95%
With sodium hydroxide In water; ethyl acetate at 0 - 5℃; for 0.5h;
With sodium hydroxide In ethanol at 20℃; for 1h; Cooling with ice;
With sodium hydroxide In ethanol for 2h; Cooling with ice;
acryloyl chloride
814-68-6

acryloyl chloride

N-(furan-2-carbonyl)piperazine
40172-95-0

N-(furan-2-carbonyl)piperazine

1-(4-(furan-2-carbonyl)piperazin-1-yl)prop-2-en-1-one

1-(4-(furan-2-carbonyl)piperazin-1-yl)prop-2-en-1-one

Conditions
ConditionsYield
With triethylamine In dichloromethane at 0 - 20℃; for 24.3333h; Inert atmosphere;95%
With triethylamine In dichloromethane at 0 - 20℃; for 24.3333h; Inert atmosphere;95%
4-(chloromethyl)-N-cyclohexylbenzamide
864265-14-5

4-(chloromethyl)-N-cyclohexylbenzamide

N-(furan-2-carbonyl)piperazine
40172-95-0

N-(furan-2-carbonyl)piperazine

N-cyclohexyl-4-[4-(2-furoyl)-1-piperazinyl]methylbenzamide

N-cyclohexyl-4-[4-(2-furoyl)-1-piperazinyl]methylbenzamide

Conditions
ConditionsYield
Stage #1: N-(furan-2-carbonyl)piperazine With potassium carbonate In acetonitrile for 0.5h; Reflux;
Stage #2: 4-(chloromethyl)-N-cyclohexylbenzamide In acetonitrile
94%
7-chloro-1-(2,4-difluorophenyl)-1,4-dihydro-8-methyl-6-nitro-4-oxoquinolone-3-carboxylic acid
1146300-32-4

7-chloro-1-(2,4-difluorophenyl)-1,4-dihydro-8-methyl-6-nitro-4-oxoquinolone-3-carboxylic acid

N-(furan-2-carbonyl)piperazine
40172-95-0

N-(furan-2-carbonyl)piperazine

1-(2,4-difluorophenyl)-1,4-dihydro-7-(4-(2-furoyl)piperazin-1-yl)-8-methyl-6-nitro-4-oxoquinoline-3-carboxylic acid
1146300-52-8

1-(2,4-difluorophenyl)-1,4-dihydro-7-(4-(2-furoyl)piperazin-1-yl)-8-methyl-6-nitro-4-oxoquinoline-3-carboxylic acid

Conditions
ConditionsYield
With potassium carbonate In dimethyl sulfoxide Microwave irradiation;93%
2-chloro-N-(2-chloro-5-(trifluoromethyl)phenyl)acetamide
328-26-7

2-chloro-N-(2-chloro-5-(trifluoromethyl)phenyl)acetamide

N-(furan-2-carbonyl)piperazine
40172-95-0

N-(furan-2-carbonyl)piperazine

N-(2-chloro-5-(trifluoromethyl)phenyl)-2-(4-(furan-2-carbonyl)piperazin-1-yl)acetamide
899713-86-1

N-(2-chloro-5-(trifluoromethyl)phenyl)-2-(4-(furan-2-carbonyl)piperazin-1-yl)acetamide

Conditions
ConditionsYield
With potassium carbonate at 60℃; for 12h; Inert atmosphere;93%
tert-butylisonitrile
119072-55-8, 7188-38-7

tert-butylisonitrile

1-formyl-3-ethoxycarbonyl-β-carboline
1356545-79-3

1-formyl-3-ethoxycarbonyl-β-carboline

N-(furan-2-carbonyl)piperazine
40172-95-0

N-(furan-2-carbonyl)piperazine

ethyl 1-((1-tert-butyl-1H-tetrazol-5-yl)(4-(furan-2-carbonyl)piperazin-1-yl)methyl)-9H-pyrido[3,4-b]indole-3-carboxylate

ethyl 1-((1-tert-butyl-1H-tetrazol-5-yl)(4-(furan-2-carbonyl)piperazin-1-yl)methyl)-9H-pyrido[3,4-b]indole-3-carboxylate

Conditions
ConditionsYield
Stage #1: tert-butylisonitrile; 1-formyl-3-ethoxycarbonyl-β-carboline; N-(furan-2-carbonyl)piperazine In methanol at 20℃; for 0.166667h; Ugi Condensation;
Stage #2: With sodium azide In methanol at 20℃;
92%
C16H14O4

C16H14O4

N-(furan-2-carbonyl)piperazine
40172-95-0

N-(furan-2-carbonyl)piperazine

1-(2-furoyl)-4-{3-[4-(methoxycarbonylmethyl)phenoxy]benzyl}piperazine

1-(2-furoyl)-4-{3-[4-(methoxycarbonylmethyl)phenoxy]benzyl}piperazine

Conditions
ConditionsYield
With sodium tris(acetoxy)borohydride In dichloromethane at 20℃; Inert atmosphere;92%
N-(furan-2-carbonyl)piperazine
40172-95-0

N-(furan-2-carbonyl)piperazine

2-isothiocyanato-4,5-dimethoxybenzonitrile
43091-89-0

2-isothiocyanato-4,5-dimethoxybenzonitrile

3,4-Dimethoxy-6-<4-(2-furoyl)piperazin-1-ylthiocarbamido>benzonitrile
67817-56-5

3,4-Dimethoxy-6-<4-(2-furoyl)piperazin-1-ylthiocarbamido>benzonitrile

Conditions
ConditionsYield
In ethyl acetate at 0℃; for 20h;90%
C10H9Br4NO2

C10H9Br4NO2

N-(furan-2-carbonyl)piperazine
40172-95-0

N-(furan-2-carbonyl)piperazine

2,4,6-tribromophenyl 3-[4-(2-furoyl)-1-piperazinyl]propylcarbamate

2,4,6-tribromophenyl 3-[4-(2-furoyl)-1-piperazinyl]propylcarbamate

Conditions
ConditionsYield
Stage #1: N-(furan-2-carbonyl)piperazine With potassium carbonate In acetonitrile for 0.5h; Reflux;
Stage #2: C10H9Br4NO2 In acetonitrile Reflux;
90%
O-phenyl N-(2-chloroethyl)-carbamate
96783-89-0

O-phenyl N-(2-chloroethyl)-carbamate

N-(furan-2-carbonyl)piperazine
40172-95-0

N-(furan-2-carbonyl)piperazine

phenyl 2-[4-(2-furoyl)-1-piperazinyl]ethylcarbamate

phenyl 2-[4-(2-furoyl)-1-piperazinyl]ethylcarbamate

Conditions
ConditionsYield
Stage #1: N-(furan-2-carbonyl)piperazine With potassium carbonate In acetonitrile for 0.5h; Reflux;
Stage #2: O-phenyl N-(2-chloroethyl)-carbamate In acetonitrile Reflux;
90%
N-(furan-2-carbonyl)piperazine
40172-95-0

N-(furan-2-carbonyl)piperazine

N-benzyl-4-(chloromethyl)benzamide

N-benzyl-4-(chloromethyl)benzamide

N-benzyl-4-[4-(2-furoyl)-1-piperazinyl]methylbenzamide

N-benzyl-4-[4-(2-furoyl)-1-piperazinyl]methylbenzamide

Conditions
ConditionsYield
Stage #1: N-(furan-2-carbonyl)piperazine With potassium carbonate In acetonitrile for 0.5h; Reflux;
Stage #2: N-benzyl-4-(chloromethyl)benzamide In acetonitrile
90%
4-amino-2-chloro-7,8-dihydro-1H-[1,4]dioxino[2,3-g]quinazoline
52759-43-0

4-amino-2-chloro-7,8-dihydro-1H-[1,4]dioxino[2,3-g]quinazoline

N-(furan-2-carbonyl)piperazine
40172-95-0

N-(furan-2-carbonyl)piperazine

[4-(4-amino-7,8-dihydro[1,4]dioxino[2,3-g]quinazolin-2-yl)piperazin-1-yl]furan-2-yl methanone hydrochloride
1067672-06-3

[4-(4-amino-7,8-dihydro[1,4]dioxino[2,3-g]quinazolin-2-yl)piperazin-1-yl]furan-2-yl methanone hydrochloride

Conditions
ConditionsYield
In pentan-1-ol for 1h; Heating;89%
methacryloyl anhydride
760-93-0

methacryloyl anhydride

N-(furan-2-carbonyl)piperazine
40172-95-0

N-(furan-2-carbonyl)piperazine

1-(4-(furan-2-carbonyl)piperazin-1-yl)-2-methylprop-2-en-1-one

1-(4-(furan-2-carbonyl)piperazin-1-yl)-2-methylprop-2-en-1-one

Conditions
ConditionsYield
In chloroform at 0℃; for 0.25h;88%
5-bromomethyl-6-phenyl-3(2H)-pyridazinone
132814-23-4

5-bromomethyl-6-phenyl-3(2H)-pyridazinone

N-(furan-2-carbonyl)piperazine
40172-95-0

N-(furan-2-carbonyl)piperazine

6-phenyl-5-(N4-(2-furoyl)-N1-piperazinylmethyl)-2H-pyridazin-3-one
132814-15-4

6-phenyl-5-(N4-(2-furoyl)-N1-piperazinylmethyl)-2H-pyridazin-3-one

Conditions
ConditionsYield
In methanol for 12h; Ambient temperature;87%
4-isothiocyanato-1,2-dimethoxybenzene
33904-04-0

4-isothiocyanato-1,2-dimethoxybenzene

N-(furan-2-carbonyl)piperazine
40172-95-0

N-(furan-2-carbonyl)piperazine

N-(3,4-dimethoxyphenyl)-4-(2-furoyl)-1-piperazinecarbothioamide

N-(3,4-dimethoxyphenyl)-4-(2-furoyl)-1-piperazinecarbothioamide

Conditions
ConditionsYield
In ethyl acetate <5 deg C;87%
Phenyl-(β-brom-propyl)-carbamat

Phenyl-(β-brom-propyl)-carbamat

N-(furan-2-carbonyl)piperazine
40172-95-0

N-(furan-2-carbonyl)piperazine

phenyl 3-[4-(2-furoyl)-1-piperazinyl]propylcarbamate

phenyl 3-[4-(2-furoyl)-1-piperazinyl]propylcarbamate

Conditions
ConditionsYield
Stage #1: N-(furan-2-carbonyl)piperazine With potassium carbonate In acetonitrile for 0.5h; Reflux;
Stage #2: Phenyl-(β-brom-propyl)-carbamat In acetonitrile Reflux;
87%
3-Chloromethyl-N-cyclohexyl-benzamide

3-Chloromethyl-N-cyclohexyl-benzamide

N-(furan-2-carbonyl)piperazine
40172-95-0

N-(furan-2-carbonyl)piperazine

N-cyclohexyl-3-{[4-(2-furoyl)-1-piperazinyl]methyl}benzamide

N-cyclohexyl-3-{[4-(2-furoyl)-1-piperazinyl]methyl}benzamide

Conditions
ConditionsYield
Stage #1: N-(furan-2-carbonyl)piperazine With potassium carbonate In acetonitrile for 0.5h; Reflux;
Stage #2: 3-Chloromethyl-N-cyclohexyl-benzamide In acetonitrile
87%
dimethyl sulfoxide
67-68-5

dimethyl sulfoxide

N-(furan-2-carbonyl)piperazine
40172-95-0

N-(furan-2-carbonyl)piperazine

furan-2-yl(4-(methylsulfonyl)piperazin-1-yl)methanone

furan-2-yl(4-(methylsulfonyl)piperazin-1-yl)methanone

Conditions
ConditionsYield
With potassium iodide at 20℃; for 8h; Electrolysis;87%
1-tert-butyl-7-chloro-1-1,4-dihydro-8-methyl-6-nitro-4-oxoquinolone-3-carboxylic acid
1146300-33-5

1-tert-butyl-7-chloro-1-1,4-dihydro-8-methyl-6-nitro-4-oxoquinolone-3-carboxylic acid

N-(furan-2-carbonyl)piperazine
40172-95-0

N-(furan-2-carbonyl)piperazine

1-tert-butyl-1,4-dihydro-7-(4-(2-furoyl)piperazin-1-yl)-8-methyl-6-nitro-4-oxoquinoline-3-carboxylic acid
1146300-69-7

1-tert-butyl-1,4-dihydro-7-(4-(2-furoyl)piperazin-1-yl)-8-methyl-6-nitro-4-oxoquinoline-3-carboxylic acid

Conditions
ConditionsYield
With potassium carbonate In dimethyl sulfoxide Microwave irradiation;86%
C10H9BrN4O8

C10H9BrN4O8

N-(furan-2-carbonyl)piperazine
40172-95-0

N-(furan-2-carbonyl)piperazine

2,4,6-trinitrophenyl 3-[4-(2-furoyl)-1-piperazinyl]propylcarbamate

2,4,6-trinitrophenyl 3-[4-(2-furoyl)-1-piperazinyl]propylcarbamate

Conditions
ConditionsYield
Stage #1: N-(furan-2-carbonyl)piperazine With potassium carbonate In acetonitrile for 0.5h; Reflux;
Stage #2: C10H9BrN4O8 In acetonitrile Reflux;
86%
6‐benzyl‐2‐chloro‐N‐(5‐methyl-1H‐pyrazol‐3‐yl)pyrimidin‐4‐amine

6‐benzyl‐2‐chloro‐N‐(5‐methyl-1H‐pyrazol‐3‐yl)pyrimidin‐4‐amine

N-(furan-2-carbonyl)piperazine
40172-95-0

N-(furan-2-carbonyl)piperazine

{4‐{4‐benzyl‐6‐[(5‐methyl‐1H‐pyrazol‐3‐yl)amino]pyrimidin‐2‐yl}piperazin‐1‐yl}(furan‐2‐yl)methanone

{4‐{4‐benzyl‐6‐[(5‐methyl‐1H‐pyrazol‐3‐yl)amino]pyrimidin‐2‐yl}piperazin‐1‐yl}(furan‐2‐yl)methanone

Conditions
ConditionsYield
With triethylamine In iso-butanol at 135℃; for 12h; Sealed tube;85.1%
7-chloro-1-cyclopropyl-1,4-dihydro-8-methyl-6-nitro-4-oxoquinolone-3-carboxylic acid
1146300-31-3

7-chloro-1-cyclopropyl-1,4-dihydro-8-methyl-6-nitro-4-oxoquinolone-3-carboxylic acid

N-(furan-2-carbonyl)piperazine
40172-95-0

N-(furan-2-carbonyl)piperazine

1-cyclopropyl-1,4-dihydro-7-(4-(2-furoyl)piperazin-1-yl)-8-methyl-6-nitro-4-oxoquinoline-3-carboxylic acid
1146300-35-7

1-cyclopropyl-1,4-dihydro-7-(4-(2-furoyl)piperazin-1-yl)-8-methyl-6-nitro-4-oxoquinoline-3-carboxylic acid

Conditions
ConditionsYield
With potassium carbonate In dimethyl sulfoxide Microwave irradiation;85%
C9H7Br3ClNO2

C9H7Br3ClNO2

N-(furan-2-carbonyl)piperazine
40172-95-0

N-(furan-2-carbonyl)piperazine

2,4,6-tribromophenyl 2-[4-(2-furoyl)-1-piperazinyl]ethylcarbamate

2,4,6-tribromophenyl 2-[4-(2-furoyl)-1-piperazinyl]ethylcarbamate

Conditions
ConditionsYield
Stage #1: N-(furan-2-carbonyl)piperazine With potassium carbonate In acetonitrile for 0.5h; Reflux;
Stage #2: C9H7Br3ClNO2 In acetonitrile Reflux;
85%

40172-95-0Relevant articles and documents

Development of novel human lactate dehydrogenase A inhibitors: High-throughput screening, synthesis, and biological evaluations

Zhou, Yuan,Tao, Pingde,Wang, Meigui,Xu, Peng,Lu, Wei,Lei, Pan,You, Qiuyun

, p. 105 - 115 (2019)

Human lactate dehydrogenase A (LDHA) plays a critical role in the glycolytic process, making the enzyme an ideal of anti-cancer drug target. Herein, we report the discovery of novel potent LDHA inhibitors by screening an in-house library. The hit-to-lead modification enabled us to identify compound 24c, which inhibited LDHA activity with an EC50 value of 90 nM, and reduced MiaPaCa-2 cancer cell proliferation with an IC50 value of 2.1 μM. In line with the in vitro anticancer activity, 24c suppressed the tumor growth at a dose of 10 mg/kg in a MiaPaCa-2 cells xenograft model, but with little effect to the mice weight. Moreover, 24c strongly inhibited MiaPaCa-2 cell colonies formation, induced MiaPaCa-2 cell apoptosis, and arrested MiaPaCa-2 cell cycle at G2 phase. In addition, the mitochondrial bioenergetics analysis suggested that 24c could reprogram cancer cell metabolic pathways from glycolysis to oxidation phosphorylation, which verified by decreasing the extracellular acidification rates and lactate formation, and increasing oxygen consumption rate in cancer cell. All these results indicate 24c is a promising metabolic modulator for the anticancer drug development.

Reactions of 4-Nitrophenyl 5-substituted Furan-2-carboxylates with R2NH/R2NH2+ in 20 mol% DMSO(aq): Effect of Aryl Group on the Acyl-Transfer Reaction

Pyun, Sang Yong,Paik, Kyu Cheol,Han, Man So,Cho, Bong Rae

, p. 994 - 1000 (2021/05/11)

Reactions of 4-nitrophenyl 2-furoates (1a–e) with R2NH/R2NH2+ in 20 mol% DMSO(aq) have been studied. The reactions produced aminolysis products and exhibited second-order kinetics. The Br?nsted plots were linear with βnuc values of 0.75–0.89, which remained nearly the same for all 5-furyl substituents. The rate data showed excellent correlations on the Yukawa-Tsuno plots with ρ(x)?=?0.72–1.1, and r?=?0.55–0.95, respectively. The ρ value increased and r value decreased with a stronger nucleophile, indicating an increase in the electron density at the C-O bond and a decrease in the resonance contribution. The results have been interpreted with the addition–elimination mechanism in which the second step is the rds. By comparing with the data for ArC(O)OC6H4-4-NO2 (Ar?=?Ph, thienyl), the effect of the aryl group on the acyl transfer reaction was assessed.

Synthesis and evaluation of 2-(4-[4-acetylpiperazine-1-carbonyl] phenyl)-1H-benzo[d]imidazole-4-carboxamide derivatives as potential PARP-1 inhibitors and preliminary study on structure-activity relationship

Cao, Xuan,Chen, Miaojia,Huang, Honglin,Jiang, Lizhi,Li, Yang,Liu, Yunfan,Peng, Junmei,Tang, Guotao,Wu, Kaiyue

, (2021/06/25)

Although 1H-benzo[d]imidazole-4-carboxamide derivatives have been explored for a long time, the structure–activity relationship of the substituents in the hydrophobic pocket (AD binding sites) has not thoroughly discovered. Here in, a series of 2-(4-[4-acetylpiperazine-1-carbonyl]phenyl)-1H-benzo[d]imidazole-4-carboxamide derivatives have been designed, synthesized, and successful characterization as novel and effective poly ADP-ribose polymerases (PARP)-1 inhibitors to improve the structure–activity relationships about the substituents in the hydrophobic pocket. These derivatives were evaluated for their PARP-1 inhibitory activity and cellular inhibitory against BRCA-1 deficient cells (MDA-MB-436) and wild cells (MCF-7) using PARP kit assay and MTT method. The results indicated that compared with other heterocyclic compounds, furan ring-substituted derivatives 14n-14q showed better PARP-1 inhibitory activity. Among this derivatives, compound 14p displayed the strongest inhibitory effects on PARP-1 enzyme (IC50?=?0.023 μM), which was close to that of Olaparib. 14p (IC50?=?43.56 ± 0.69 μM) and 14q (IC50?=?36.69 ± 0.83 μM) displayed good antiproliferation activity on MDA-MB-436 cells and inactivity on MCF-7 cells, indicating that 14p and 14q have high selectivity and targeting. The molecular docking method was used to explore the binding mode of compound 14p and PARP-1, and implied that the formation of hydrogen bond was essential for PARP-1 inhibition activities. This study also showed that in the hydrophobic pocket (AD binding sites), the introduction of strong electronegative groups (furan ring, e.g.) or halogen atoms in the side chain of benzimidazole might improve its inhibitory activity and this strategy could be applied in further research.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 40172-95-0